Evidence map›Paper›PMID 40715419›Full record

Reviewnpj antimicrobials and resistance2025

Inter- and intra-bacterial strain diversity remains the "elephant in the (living) room".

Adam Valcek, Carsten Kröger, Rubén de Dios, Ronan R McCarthy, Tom Coenye, M Stephen Trent, Nabil Karah, Bernt Eric Uhlin, Annika Y Classen, Paul G Higgins and 6 more

Abstract readReview
In one paragraph

Review in npj antimicrobials and resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Adam ValcekMicrobial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium.
Carsten KrögerDepartment of Microbiology, School of Genetics and Microbiology, Moyne Institute of Preventive Medicine, Trinity College Dublin, Dublin 2, Ireland.
Rubén de DiosCentre for Antimicrobial Innovations, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.
Ronan R McCarthyCentre for Antimicrobial Innovations, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, UB8 3PH, UK.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
M Stephen TrentDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
Nabil KarahDepartment of Molecular Biology, Umeå Centre for Microbial Research (UCMR), Umeå University, SE-901 87, Umeå, Sweden.
Bernt Eric UhlinDepartment of Molecular Biology, Umeå Centre for Microbial Research (UCMR), Umeå University, SE-901 87, Umeå, Sweden.
Annika Y ClassenInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935, Cologne, Germany.
Paul G HigginsInstitute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50935, Cologne, Germany.
Ingo EbersbergerFaculty of Biological Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Maria-Halima LaaberkiUniversité de Lyon, VetAgro Sup, Lyon, France.
Xavier CharpentierCIRI, Centre International de Recherche en Infectiologie, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ, Lyon, France.
Paolo ViscaDepartment of Science, Roma Tre University, Rome, Italy.
Philip N RatherDepartment of Microbiology and Immunology, Emory University School of Medicine and Research Service, Atlanta VA Medical Center, 30033, Atlanta, GA, USA.
Charles Van der HenstMicrobial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, Brussels, Belgium. charles.vanderhenst@vub.vib.be.

Funding

The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumanniiR01AI150098 · NIAID · UNIVERSITY OF GEORGIA · PI Michael Stephen Trent · 2020 to 2026
$3.9M
NIAID NIH HHS R01 AI150098
6 · The paper itself

Abstract

Acinetobacter baumannii is an opportunistic Gram-negative bacterial pathogen responsible for severe nosocomial infections worldwide. Resistance to last-resort antibiotics causes A. baumannii to be ranked as a top priority for the research and development of new antibiotics by the WHO and an urgent threat to public health by the CDC. It is also a member of the ESKAPE group comprising the most problematic antibiotic-resistant nosocomial pathogens. Resistance towards desiccation, disinfectants, reactive oxygen species, and the host immune system helps A. baumannii thrive in hospital settings and infect individuals compromised by lines, tubes, and indwelling devices. A. baumannii displays extensive genomic heterogeneity, yet recent studies show that this level of plasticity is also prevalent in lab strains widely used to study A. baumannii biology. Successive subculturing of widely used strains and spontaneous genetic variations results in significantly altered genotypes and phenotypes, often not recognized by the scientific community. In addition, the current strain designation methods do not allow efficient communication about such differences. Even presumably identical strains from established culture collections have been found to demonstrate genetic heterogeneity. The "elephant in the (living) room" refers to the risk but also the potential of the bi-partite problem concerning the high diversity amongst A. baumannii isolates (inter-strain variability), and the universal issue of microevolution (intra-strain variability). This is generally ignored as it is not referenced adequately in scientific publications. We aim to raise awareness about the current issues and the problematic consequences generated by intra- and inter-strain diversity based on modern examples of A. baumannii isolates. Therefore, this review provides cases of broadly used A. baumannii strains and their genetic and phenotypic differences.

Identifiers

PMID40715419
PMCPMC12297434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.